Home > Name List By 4 > 4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide

CAS No 169590-42-5 , 4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide

  • Name: 4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
  • Synonyms: Celecoxi; Onsenal;Celebrex; Celocoxib; Celebra;4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide; SC 58635; Xilebao; Celecox; 169590-42-5;
  • CAS Registry Number:
  • Transport: UN 2811
  • Melting Point: 157-159 ºC
  • Boiling Point:
  • Density: 1.43 g/cm3
  • Water Solubility: Insoluble
  • Safety Statements: S22;S24/25;S28;S37/39;
  • Hazard Symbols: UN NO.
  • Molecular Weight: 381.37217
  • InchiKey: RZEKVGVHFLEQIL-UHFFFAOYSA-N
  • InChI: InChI=1S/C17H14F3N3O2S/c1-11-2-4-12(5-3-11)15-10-16(17(18,
    19)20)22-23(15)13-6-8-14(9-7-13)26(21,24)25/h2-10H,1H3,(H2,21,24,25)
  • Risk Statements: R20/21/22
  • Molecular Formula: C17H14F3N3O2S
  • Molecular Structure:CAS No:169590-42-5 4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide

Related products

Search by region :

Select to

169590-42-5 Celecoxib

  • Celecoxib, 99%
  • China henglidahuagong co,.Ltd [Manufacturer]
  • Tel: 13996793719
  • Fax: 86+(0535?2260023
  • Address: NO 238,CANAN ROAD NORTH OF WENCANG,LAIZHOU CITY,SHANGDONG,CHINA LAIZHOU CITYCHINA LAIZHOU CITY,nullChina
Contact Supplier

169590-42-5 Celecoxib

  • India JAI RADHE SALES null
  • Fax: 0091-79-26569884
  • Address: 309/310 HARIKRUPA TOWER,NR.OLD SHARDA MANDIR CHAR RASTA,ELLISBRIDGE ,AHMEDABAD,GUJRAT , INDIA. null,nullIndia
Contact Supplier

169590-42-5; 184007-95-2 CELECOXIB

  • India JAI RADHE SALES null
  • Fax: 0091-79-26569884
  • Address: 309/310 HARIKRUPA TOWER,NR.OLD SHARDA MANDIR CHAR RASTA,ELLISBRIDGE ,AHMEDABAD,GUJRAT , INDIA. null,nullIndia
Contact Supplier

169590-42-5 CELECOXIB

Contact Supplier

169590-42-5 Celecoxib

Contact Supplier

169590-42-5 Celecoxib

  • India Triveni Chemicals null
  • Tel: +91-(260)-2400022, 3258683
  • Fax: +91-(260)-2400022/3264008
  • Address: 135, Pancharatna, Char Rasta, G.I.D.C., Vapi, Gujarat 396 195, null,nullIndia
Contact Supplier

169590-42-5 Celecoxib

  • China HuaiBei SanHe Developing Co., Ltd. [Manufacturers]
  • Tel: 86-561-3191113
  • Fax: +86-561-3192253
  • Address: Room 201,Building ZY-1,GuCheng Road,Huaibei,Anhui,China null,anhuiChina
Contact Supplier

169590-42-5; 184007-95-2 Celecoxib

  • China HuaiBei SanHe Developing Co., Ltd. [Manufacturers]
  • Tel: 86-561-3191113
  • Fax: +86-561-3192253
  • Address: Room 201,Building ZY-1,GuCheng Road,Huaibei,Anhui,China null,anhuiChina
Contact Supplier

169590-42-5 Celecoxib

  • India Manus Aktteva null
  • Tel: +91-(79)-65123395
  • Fax: +91-(79)-26463395
  • Address: 303, 3rd Floor, Royale Manor, Law Garden, Dhulia Kot Road, Ellisbridge, Ahmedabad, Gujarat 380006, null,nullIndia
Contact Supplier

169590-42-5 Celecoxib

  • Celecoxib, 98%
  • United Kingdom Cardiff Chemicals Limited [Manufacturer]
  • Tel: +44(0) 29 20 779612
  • Fax: +44(0) 29 20 779612
  • Address: Unit 10, CF3 0EF CardiffUNITED KINGDOM CF3 0EF Cardiff,nullUnited Kingdom
Contact Supplier

Select to

4/12
Previous 1 2 3 4 5 6 7 8 9 10 Next
References of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
Title: Celecoxib
CAS Registry Number: 169590-42-5
CAS Name: 4-[5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide
Manufacturers' Codes: SC-58635; YM-177
Trademarks: Celebrex (Pfizer); Onsenal (Pfizer)
Molecular Formula: C17H14F3N3O2S
Molecular Weight: 381.37
Percent Composition: C 53.54%, H 3.70%, F 14.94%, N 11.02%, O 8.39%, S 8.41%
Literature References: Selective cyclooxygenase-2 (COX-2) inhibitor. Prepn: J. J. Talley et al., WO 9515316; eidem, US 5466823 (both 1995 to Searle); T. D. Penning et al., J. Med. Chem. 40, 1347 (1997). Clinical pharmacology: P. E. Lipsky, P. C. Isakson, J. Rheumatol. 24, Suppl. 49, 9 (1997). Clinical trials in arthritis: L. S. Simon et al., Arthritis Rheum. 41, 1591 (1998). Evaluation of risk of gastrointestinal toxicity in patients with arthritis: F. E. Silverstein et al., J. Am. Med. Assoc. 284, 1247 (2000). Clinical trial in familial adenomatous polyposis: G. Steinbach et al., N. Engl. J. Med. 342, 1946 (2000).
Properties: Pale yellow solid, mp 157-159°.
Melting point: mp 157-159°
Therap-Cat: Anti-inflammatory. In treatment of familial adenomatous polyposis.
Keywords: Anti-inflammatory (Nonsteroidal); Cyclooxygenase-2 Selective Inhibitor.